Title: Recommendation Rating: ADA Obesity Management Recommendation 8.16


Rating for Recommendation: Recommendation: ADA Obesity Management Recommendation 8.16


ConceptSummaryRating
Rating System (coded as: rating-system from https://fevir.net/resources/CodeSystem/179423)undefinedADA Level of Evidence
Direction of Recommendation (coded as: direction-of-recommendation from https://fevir.net/resources/CodeSystem/179423)undefinedFavors intervention (coded as: RJCS-2021 from https://fevir.net/resources/CodeSystem/27834)
Ratings (coded as: ratings from https://fevir.net/resources/CodeSystem/179423)undefinedA
Certainty of Evidence (coded as: certainty-of-evidence from https://fevir.net/resources/CodeSystem/179423)A substantial body of evidence has now been accumulated, including data from numerous randomized controlled (nonblinded) clinical trials, demonstrating that metabolic surgery achieves superior glycemic control and reduction of cardiovascular risk factors in patients with type 2 diabetes and obesity compared with various lifestyle/medical interventions.ADA Level of Evidence A

 <citeAs value="Recommendation Rating: ADA Obesity Management Recommendation 8.16 [Database Entry: FHIR ArtifactAssessment Resource]. Contributors: In: Fast Evidence Interoperability Resources (FEvIR) Platform, FOI 385882. Revised 2025-08-14. Available at: https://fevir.net/resources/ArtifactAssessment/385882. Computable resource at: https://fevir.net/resources/ArtifactAssessment/385882#json."/> <artifactReference> <reference value="Composition/179466"/> <type value="Composition"/> <display value="Recommendation: ADA Obesity Management Recommendation 8.16"/> </artifactReference> <relatesTo> <type value="derived-from"/> <targetReference> <reference value="ArtifactAssessment/179469"/> <type value="ArtifactAssessment"/> <display value="Justification for Recommendation: ADA Obesity Management Recommendation 8.16"/> </targetReference> </relatesTo> <content> <type> <coding> <system value="https://fevir.net/resources/CodeSystem/179423"/> <code value="rating-system"/> <display value="Rating System"/> </coding> </type> <classifier> <text value="ADA Level of Evidence"/> </classifier> <freeToShare value="true"/> </content> <content> <type> <coding> <system value="https://fevir.net/resources/CodeSystem/179423"/> <code value="strength-of-recommendation"/> <display value="Strength of Recommendation"/> </coding> </type> <freeToShare value="true"/> </content> <content> <type> <coding> <system value="https://fevir.net/resources/CodeSystem/179423"/> <code value="direction-of-recommendation"/> <display value="Direction of Recommendation"/> </coding> </type> <classifier> <coding> <system value="https://fevir.net/resources/CodeSystem/27834"/> <code value="RJCS-2021"/> <display value="Favors intervention"/> </coding> </classifier> <freeToShare value="true"/> </content> <content> <summary value="A substantial body of evidence has now been accumulated, including data from numerous randomized controlled (nonblinded) clinical trials, demonstrating that metabolic surgery achieves superior glycemic control and reduction of cardiovascular risk factors in patients with type 2 diabetes and obesity compared with various lifestyle/medical interventions."/> <type> <coding> <system value="https://fevir.net/resources/CodeSystem/179423"/> <code value="certainty-of-evidence"/> <display value="Certainty of Evidence"/> </coding> </type> <classifier> <text value="ADA Level of Evidence A"/> </classifier> <freeToShare value="true"/> </content> <content> <type> <coding> <system value="https://fevir.net/resources/CodeSystem/179423"/> <code value="ratings"/> <display value="Ratings"/> </coding> </type> <classifier> <text value="A"/> </classifier> <freeToShare value="true"/> </content> </ArtifactAssessment>